TRIPLE I NEWS

Triple I Clinical Academic Group: Infectious Disease, Immunity and Inflammation
Maridulu Budyari Gumal SPHERE: Sydney Partnership for Health, Education, Research and Enterprise 

12 FEBRUARY 2021

News

Triple I Annual Meeting
Join us for the Triple I Clinical Academic Group Annual Meeting. This will be a combined face-to-face/online meeting, with the presenters and other members encouraged to attend in person (max. 60 people). Due to anticipated attendee numbers and current COVID restrictions, the event will be held at the Scientia Building, UNSW Sydney.  

Program 2021

• 9.00 AM  Welcome and Triple I Update – Anthony Kelleher, Triple I Clinical Academic Group Leader
• 9.20 AM  Maridulu Budyari Gumal, SPHERE/AHRA Update – Rowena Tucker, Acting Executive Director
• 9.40 AM  Panel discussion - Triple I COVID response – who is doing what and how can we optimise impact?
• 10.30 AM Seed funding report back session 
• 11.30 AM Planning and partnerships – what are the next steps?
• 12.10 PM  Summary and close - Anthony Kelleher

When: 1 April 2021 (8.30 AM - 12.30 PM)
Where: Scientia Building, UNSW and online (streaming access details TBA)

Register for face-to-face event
 

Hold the Date: Cancer Immunology Ideas Forum, 21 May 2021
Immune checkpoint inhibitors, CAR-T cells and cancer vaccines are changing the way clinicians are managing malignancies, and the prognosis of people living with cancer. But it’s only the beginning. The inaugural Cancer Immunology Ideas Forum brings together the pre-clinical, translational and clinical research community for presentation of work, scientific discussion and research brainstorming.This will be a day of collegiality and collaboration for those working on this frontier of medicine.
When: 21 May 2021. Further details TBA.  
 

Inherited immune condition reversed by random DNA change
Researchers at the Garvan Institute of Medical Research have revealed how a rare DNA change rebalanced the immune system of patients with a life-threatening genetic immunodeficiency.
Read more
 

ASCIA COVID-19 Update
The ASCIA COVID-19 Working Party has developed new documents to provide guidance about allergy, immunodeficiency, autoimmunity and COVID-19 vaccination, in preparation for the COVID-19 vaccination programs in Australia and New Zealand.
Read more
 

Events & Opportunities 

Survey: E/MCR women researchers
AHRA Women's Health Research, Translation and Impact Network seek participants in their national survey for E/MCR women researchers to help identify ways to better strengthen and support women in early and mid-stages of their career. 
Survey
 

Modelling the impact of PrEP on gonorrhoea incidence: UNSW ResTech Seminar
In this seminar, Michael Walker discusses using high performance computing (HPC) to model PrEP on incidences of gonorrhoea.
When: 25 February 2021
Read more
 

Webinar: Publishing your Research - Publish or Perish?
This session for health professionals who are considering or planning to publish their  work It will outline the publication and peer review processes, how to respond to feedback and common errors in journal submissions.
When: 3 March 2021
Read more
 

Inferior: Caroline Ford in conversation with Angela Saini 
British science journalist and author, Angela Saini, joins leading cancer researcher Caroline Ford for a conversation about bias in science, medicine and the public understanding of gender, and how to build a more accurate picture of human difference.
When: 8 March 2021 (International Women's Day)
Read more
 

Guidelines and Impact: the art of storytelling
This webinar, will describe ways in which you can use data and present impact through case studies.
When: 12 March 2021
Read more
 

Australian Polygenic risk symposium
The second Australian Polygenic Risk Symposium will held virtually, bringing together researchers, clinicians, educators and industry to focus on the applications of polygenic risk and its clinical implementation.
When: 20 - 22 April 2021
Read more
 

Treating Hepatitis C in General Practice Forum 2021
This forum brings GPs together to discuss their experiences, strategies for success, and innovative models of care for the treatment of people living with hepatitis C. ASHM and the Kirby Institute are offering scholarships for GPs who submit an abstract to attend the 12th Australasian Viral Hepatitis Conference. 
When: 29 May 2021
Read more
 

12th Australasian Viral Hepatitis Conference
This year's conference theme is Progress towards hepatitis elimination targets: Taking stock and innovating for the future. The conference will combine face-to-face Sydney and Brisbane hubs and live-streaming. 
When: 30 May - 1 June 2021
Read more
 

Funding

L’Oréal/UNESCO for women in science Fellowships
Four $25K Australian fellowships are available for a one year project. This is intended to provide practical help for the winners to undertake research in their chosen fields and the winners may choose to spend their fellowship on buying scientific equipment, paying for child care costs, conference & travel costs or other items needed to continue their research. 
Deadline: 1 March 2021
Read more
 

Global Innovation Linkages Program - Round 3
The Global Innovation Linkages Program provides funding to help Australian businesses and researchers collaborate with global partners. Priority areas include medical technologies and pharmaceuticals. 
Deadline: 7 April 2021
Read more
 

MRFF Funding Opportunities

• 2020 International Clinical Trial Collaborations Round 2 Deadline: 3 Mar 2021
• 2020 Stem Cell Therapies Deadline: 3 March 2021
• 2020 Genomics Health Futures Mission  Deadline: 3 March 2021
• 2020 Improving Diagnosis in Cancers with Low Survival Rates Deadline: 10 March 2021
• 2020 Paediatric Cancer  Deadline: 10 March 2021
   

NHMRC 2021 Funding Opportunities

• 2021 Investigator Grants Deadline: 31 March 2021
• Partnership Project 2021 PRC1 Deadline: 7 April 2021
• 2021 Synergy Grants Deadline: 21 April 2021
• 2021 Ideas Grants Deadline: 5 May 2021
   

Triple I Vision: A world where human health is enriched by controlling infection, enhancing immunity and managing inflammation.